Insider Trading Alert - QDEL, SPRT And SJW Traded By Insiders

Yesterday, Aug. 3, 2016, 83 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $159.80 to $31,200,000.00.

Highlighted Stocks Traded by Insiders:

Quidel (QDEL) - FREE Research Report

Tamerius John, who is SVP, Strat & Ext Affairs at Quidel, sold 7,000 shares at $23.02 on Aug. 3, 2016. Following this transaction, the SVP, Strat & Ext Affairs owned 18,540 shares meaning that the stake was reduced by 27.41% with the 7,000-share transaction.

The shares most recently traded at $23.13, up $0.11, or 0.49% since the insider transaction. Historical insider transactions for Quidel go as follows:

  • 4-Week # shares bought: 3,700
  • 4-Week # shares sold: 5,000
  • 12-Week # shares bought: 3,700
  • 12-Week # shares sold: 5,000
  • 24-Week # shares bought: 3,700
  • 24-Week # shares sold: 5,000

The average volume for Quidel has been 112,600 shares per day over the past 30 days. Quidel has a market cap of $751.4 million and is part of the health care sector and drugs industry. Shares are up 7.55% year-to-date as of the close of trading on Friday.

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications primarily in infectious diseases, women's health, and gastrointestinal diseases. Currently, there are 3 analysts who rate Quidel a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on QDEL - FREE

TheStreet Quant Ratings rates Quidel as a sell. Among the areas we feel are negative, one of the most important has been an overall disappointing return on equity. Get the full Quidel Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Abbott CEO: Another Alere-Related Divestiture Coming Soon

Alere, St. Jude Deals in Focus as Abbott Releases Q2 Earnings

Quidel Diversifies With Alere's Triage Assets

Action Was Under the Surface in Monday's Market